Galabin, Geraldine .
HRN: 27-64-16 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2025
CEFOTAXIME 500MG (VIAL)
08/15/2025
08/21/2025
PO
500mg
Bid
Thickly
Checking Initial Appropriateness
08/15/2025
METRONIDAZOLE 500MG (TAB)
08/15/2025
08/21/2025
PO
500mg
Tid
Thickly
Checking Initial Appropriateness
08/15/2025
CEFUROXIME 500MG (TAB)
08/15/2025
08/21/2025
PO
500mg
Bid
Thickly Msaf
Checking Initial Appropriateness